Mr. Yuval Kupitz

Co-manager

Email: ykupitz@tauex.tau.ac.il

Mr. Yuval Kupitz received B.Sc. degree in Chemistry and Biology, M.Sc. in Biochemistry and an additional M.Sc. degree in Business Management and Industrial Chemistry, all from the Hebrew University of Jerusalem, Israel.

Prior to his appointment at XIN Center and Tel-Aviv University, Yuval served in various management positions in the Biotech industry.

Yuval served as a Director of Applied Biotechnology at The National Institute for Biotechnology in the Negev Ltd., developing and managing applied research programs emerging from Ben-Gurion University researchers to proof-of-principle stages, and commercializing them.

Yuval was a Vice President of Business Development-Pharmaceuticals and Diagnostics as well as of Intellectual Property at Hadasit Ltd., the technology transfer company of leading hospitals in Israel. There he experienced with dozens of out-licensing deals in the Bio/Pharma arena and in many routes for business development activities such as Start-Ups establishments and IPO's.

Prior to his 12 year tenure at Hadasit, he held various positions including at the Technology Transfer Office of the NIH, USA, at the agriculture and the science departments of the Israeli Embassy in Washington DC, and at Sigma Chemicals Ltd., a subsidiary of Sigma-Aldrich, Inc., where he served as a Production Manager.

Coronavirus: South Korea seeing a 'stabilising trend'

Mar. 15, 2020. Kang Kyung-wha, the South Korean Foreign Minister